Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2010076496) USE OF AN IMMUNOGLOBULIN G (IGG) CONCENTRATE DEPLETED OF ANTI-A AND ANTI-B ANTIBODIES FOR TREATING NEONATAL JAUNDICE CAUSED BY MATERNAL-FOETAL INCOMPATIBILITY WITH RESPECT TO THE ABO SYSTEM
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2010/076496 International Application No.: PCT/FR2009/052558
Publication Date: 08.07.2010 International Filing Date: 16.12.2009
IPC:
A61K 39/395 (2006.01) ,A61P 43/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
395
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
43
Drugs for specific purposes, not provided for in groups A61P1/-A61P41/108
Applicants:
LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES [FR/FR]; ZA de Courtaboeuf 3 avenue des Tropiques F-94940 Les Ulis, FR (AllExceptUS)
ELZAABI, Mazen [FR/FR]; FR (UsOnly)
Inventors:
ELZAABI, Mazen; FR
Agent:
NOVAGRAAF TECHNOLOGIES; 122 Rue Edouard Vaillant F-92593 Levallois-Perret Cedex, FR
Priority Data:
080710517.12.2008FR
Title (EN) USE OF AN IMMUNOGLOBULIN G (IGG) CONCENTRATE DEPLETED OF ANTI-A AND ANTI-B ANTIBODIES FOR TREATING NEONATAL JAUNDICE CAUSED BY MATERNAL-FOETAL INCOMPATIBILITY WITH RESPECT TO THE ABO SYSTEM
(FR) UTILISATION D'UN CONCENTRE D'IMMUNOGLOBULINES G (IGG) APPAUVRI EN ANTICORPS ANTI-A ET ANTI-B POUR LE TRAITEMENT DE L'ICTERE NEONATAL PAR INCOMPATIBILITE FOETOMATERNELLE DANS LE SYSTEME ABO
Abstract:
(EN) The present invention relates to the use of an immunoglobulin G (IgG) concentrate depleted of anti-A (AcaA) and anti-B (AcaB) antibodies for producing a drug intended for treating neonatal jaundice caused by maternal-foetal incompatibility with respect to the ABO system.
(FR) La présente invention se rapporte à l'utilisation d'un concentré d'immunoglobulines G (IgG) appauvri en anticorps anti-A (AcaA) et anti-B (AcaB) pour la fabrication d'un médicament destiné au traitement de l'ictère nénonatal par incompatibilité fœtomaternelle dans le système ABO.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: French (FR)
Filing Language: French (FR)
Also published as:
EP2358391IL213618JP2012512235US20120039886CN102316899CA2748562
ES2528420CN104721819KR1020110128271BRPI0923032JP2016041754AU2009334626
FR2939667DK2358391IN2944/KOLNP/2011